European Health Union: HERA Invest offers €100 million for innovative solutions to health threats
Today, the Commission and the European Investment Bank announce the creation of HERA Invest, a €100 million top-up to the InvestEU programme, to support research and development (R&D) in the most pressing cross-border health threats, financed by the EU4Health programme. Currently, European companies find it difficult to access sufficient public and private funding for the development and scaling up of cutting-edge solutions in health and life sciences. Innovation is needed to respond to priority health threats such as pathogens with high pandemic potential or resistance to antibiotics...
Source: eib.org
